Company: ARTL
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001640334-25-001429
Chunk: 498

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-08-13
Form: 10-Q
Item: Part I, Item 1
Chunk 498
---
ences, Inc. and R.F. Lafferty & Co., Inc. (incorporated by reference to Exhibit 1.1 to the Company’s Form 8-K filed with the SEC on July 18, 2025) 8-K 001-38951 07/18/2025  10.2 Securities Purchase Agreement, dated June 24, 2025, between Artelo Biosciences, Inc. and the Purchasers named therein 8-K 001-38951 06/26/2025  10.3 Form of Subscription Agreement by and between Artelo Biosciences Inc. and the purchasers named therein 8-K 001-38951 05/01/2025  10.4 Form of Pre-Funded Warrant 8-K 001-38951 06/26/2025  10.5 Form of $5.82 Warrant 8-K 001-38951 06/26/2025  10.6 Form of $10.00 Warrant 8-K 001-38951 06/26/2025  10.7 Form of Convertible Note 8-K 001-38951 05/01/2025  10.8 Form of Warrant 8-K 001-38951 05/01/2025  31.1 Section 302 Certification       *32.1 ** Section 906 Certification       *101. INS Inline XBRL Instance Document        101. SCH Inline XBRL Taxonomy Extension Schema Document        101. CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document        101. DEF Inline XBRL Taxonomy Extension Definition Linkbase Document        101. LAB Inline XBRL Taxonomy Extension Label Linkbase Document        101. PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document        104 Cover page Interactive Data File (embedded with the Inline XBRL document)        

___________

**The certification attached as Exhibit 32.1 that accompanies this Quarterly Report on Form 10-Q, is deemed furnished and not filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Artelo Biosciences, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date